PODCAST: A Biotech Buyout, and an Influencer Uprising
By Doug Young & Rene Vanguestaine AstraZeneca has offered to buy money-losing Gracell Biotech for up to $1.2 billion, in a first-of-its kind M&A for a Chinese drug startup. Will…
Education provider TAL counts on AI devices and MathGPT
The learning solutions company has swung into the black after investing in AI-powered educational devices and developing a newly approved MathGPT tool Key Takeaways: TAL's revenue rose 40% in the…
New Oriental Education delivers a lesson in business revival
The education giant has sealed its return to financial health with quarterly adjusted profits at a three-year high and revenues back to 92% of their level before a crackdown on…
Back on a profitable track, New Oriental pivots towards travel
The education and e-commerce group has rebounded into profit from a big annual loss and is aiming to break into tourism, responding to booming post-pandemic demand Key Takeaways: New Oriental…
New school day dawns for New Oriental
The former private education services provider's latest results show its core education business is bouncing back from a major government crackdown two years ago Key Takeaways: New Oriental's revenue rose 22.8% in…
Koolearn’s New Lesson: E-Commerce Pays Better Than Education
The former education company has returned to profits on spiking revenues, pointing to early success in its transition to livestreaming e-commerceKey Takeaways:Koolearn’s revenue grew 263% in the first half of…
FAST NEWS: Koolearn Proposes New Name in Move From Education
The latest: Koolearn Technology Holding Ltd. (1797.HK) on Thursday proposed changing its name to East Buy Holding Ltd. to reflect its new business direction.Looking up: The company believes the change better aligns…
Recent Articles
New Oriental Education delivers a lesson in business revival
EDU.US
9901.HK
New school day dawns for New Oriental
EDU.US
9901.HK
RELATED ARTICLES
-
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
GRCL.US -
FAST NEWS: Gracell shareholders approve merger with AstraZeneca
GRCL.US
- CHINA BULLETIN: China-India Tensions Flare with New Arrests
- CHINA BULLETIN: PMI Readings Signal Strong End to 2023
-
Cash-strapped Viva Biotech sells stake and plans spinoff
1873.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
- ProfoundBio discovers the joys of having a wealthy owner
